ArticleScientific reports2025
The MEK inhibitor trametinib is effective in inhibiting the growth of canine oral squamous cell carcinoma.
William P Katt et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it